IDEA Collider

Embracing Innovation and Collaboration in the Pharma Industry with Dr. Nedim Pipic

Welcome to another episode of Idea Collider with your host, Mike Rea.  In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference. Join us as we explore the unmet needs in these areas, the power of hybrid approaches and precision psychiatry, and the integration of digital therapeutics.  Discover how...

Exploring the book “Quit: The Power of Knowing When to Walk Away” by Annie Duke

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Annie Duke joins us on the show to discuss her latest book, “Quit: The Power of Knowing When to Walk Away.” Annie is an Author, Professional Speaker, Decision Strategist & co-founder of The Alliance for Decision Education, a non-profit whose mission is to improve lives by empowering students through decision skills education.  In the episode, Annie Duke delves into the motivati...

The Industrial Revolution of Drug Discovery with Dr. Michael Secora

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor. In the episode, Michael delves into the reasons behind the incredibly fast growth at Recursion, the company’s mission of decoding biology to radically improve lives, the relatability of data, and how Rec...

Embracing Digital Technology for Better Healthcare with Mary Lou Jepsen

The healthcare industry is moving towards a digital revolution. With the help of digital technology, healthcare providers can now provide better and more efficient services to their patients. Digital technology has also proven to have a positive impact on patient outcomes, as well as the cost of care.  Companies such as Openwater, which focuses on creating the future of medical imaging, have been able to deliver life-saving technologies. Through the use of low-intensity ultrasound, Openwate...

Competitive Advantage & Positioning with Jaynie Smith

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today a competitive advantage expert, and CEO of Smart Advantage, Jaynie Smith, joins us on the show.  She delves into snippets in her book, Creating Competitive Advantage, & the role of competitive advantage in increasing sales and protecting profit margins.   Moreover, she explains that it’s not about prices but your value proposition, understanding your customers' top three buying ...

Exploring Compounding Pharmacy with Sherine Khalil

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Sherine Khalil, the Vice President and Chief Business Officer for Valor Compounding Pharmacy. She talks about sterile and non-sterile compounding as well as her transition from the nonprofit world to academic medicine. Additionally, she delves into the major functional areas of compounding pharmacy, the reasons behind the decline in compounding pharmacy over the...

Pricing, Value, and Innovation with Prof. Brian D Smith

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Prof. Brian D Smith, a pharma innovation geek for the past 24 years. He talks about his latest book, “ New Drugs, Fair Prices,” and how to manage the pharmaceutical innovation ecosystem for sustainable and affordable new medicines. Additionally, he delves deep into discovery habitats and how every habitat contributes to the ecosystem for a sustainable and afford...

Marketing Intelligence & Data Quality with Matthew Wahlrab

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today a tech pioneer, founder & CEO of Rapid Alpha joins us on the show as we discuss marketing intelligence & why business leaders can not ignore data quality.  Matthew talks about his career path from intellectual property to where he is now, about Rapid Alpha, what innovation management entails, and how data works and impacts company decisions. Additionally, he expounds on the righ...

Developing Effective Leadership, Strong Organizational Culture & Behavior with Tim Kight

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Tim Kight,  a long-life student of elite performance, coach, and Focus 3 CEO joins us on the show as we discuss developing leaders & strengthening organizational culture to achieve better results. Tim delves into the five drivers of organizational greatness, training your team on behavioral skills, rebuilding your company’s culture, and expanding your focus run. Additionally, h...

Asymmetric Learning and Its Impact On Culture with John Waid

Welcome to another amazing episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. In today’s episode, Mike is joined by John Waid. John is a thought leader, author, and CEO of a unique boutique global culture & leadership development firm. He talks about culture and the purpose of an organization. Additionally, he talks about the importance of knowing your; purpose, mission, values, and principles of behavior and why most professionals who are promoted based on their ...

Creativity & Innovation In Corporate Venture With Rita McGrath

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by a consultant, best-selling author, and one of the world’s top experts on strategy and innovation, Rita McGrath. In the episode, Rita talks to us about her transition from a political science career to innovation in the corporate venture, how to build an innovation program, challenges in implementation, and why you need multiple funding sources while championing ...

Using AI In Drug Discovery With Andrew Hopkins

Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Andrew Hopkins, the Founder & CEO  of Exscientia, as he talks to us about the use of AI in drug discovery.   In the episode, we delve into Andrew’s journey of developing better drug discovery methods, applying data mining in drug discovery, and the value of data integration in the pharmaceutical industry. Additionally, he expounds on what AI drugs look like and...

The Misconceptions In The Pharma Industry With John L. Lamattina

In this incredible episode, Mike Rea is joined by Dr. John L. LaMattina. John is the former Senior Vice President of Pfizer Inc and President of Pfizer Global Research & Development. Additionally, he is a senior partner at PureTech Health and an author. He talks about the misconception about Pfizer’s profiteering from the pandemic and the drug pricing in America.  John also discusses how Gilead’s Sovaldi drug for hepatitis C became overpriced in the US and the effects of insurance companies...

Asymmetric Learning in Cybersecurity & Intelligence with Gene Yoo

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. Today we are joined by Gene Yoo, the Chief Executive Officer at Resecurity, Inc. He talks about asymmetric learning in cybersecurity & Intelligence and what gives Resecurity an edge over other competitors in the market Moreover, he shares about the signal validation process at Resecurity, how to understand the vulnerability of your business and what you need to combat cyber threats....

Where Do Good Ideas Come from? With Steven Johnson

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. In today’s episode, Mike interviews Steven Johnson, an author of 13 books, a TV host, and a podcaster. He talks about Innovation vs. Invention and explains where good ideas come from.  Additionally, Steven talks about the Individual and organizational hunch collection tools and shares how organizational culture impacts innovation. Moreover, he talks about his books The Ghost Map and...

Welcome Back to Series II of IDEA Collider

Sick Money: The Truth About The Global Pharmaceutical Industry With Billy Kenber

Welcome to another fantastic episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Billy Kenber, an investigative journalist at “The Times.” He talks about his journey to writing his book ‘Sick Money’ and the content in the book. Additionally, he talks about the pharmaceutical industry’s social contract with patients and how its distortion has led to pharmaceutical greed. Moreover, he shares how the culture within the pharmaceutical industry ha...

IDEA Collider | Kabir Nath

Kabir Nath is President & CEO, Otsuka North America Pharmaceutical Business Throughout his career, Kabir has built bridges between cultures. His work has taken him across the globe, spanning 3 continents and multiple countries. Kabir has lived and worked in the United Kingdom, France, Spain, India, Singapore, China, and the United States. He has consistently inspired those around him to go beyond cultural and linguistic differences to bring new concepts and ideas to life, forging stronger pa...

IDEA Collider | Pharma Book Club | Kat Arney

 (Now also released in paperback: https://amzn.to/3lWjo2B)  Kat can be found at First Create The Media:  and on Twitter: @Kat_Arney  Find out more about Rebel Cell here: https://www.rebelcellbook.com/about-rebel-cell-cancer-book Many of us think of cancer as a contemporary killer, a disease of our own making caused by our modern lifestyles. But, as Kat Arney explains in her new book REBEL CELL: Cancer Evolution and the Science of Life, that perception just isn’t true. Although it might be...

IDEA Collider | Susanne Schaffert, PhD

As President of Novartis Oncology, Susanne Schaffert is pursuing a bold strategy to reimagine the research, development and commercialization of innovative treatments that will help improve and extend the lives of people with cancer and related blood disorders.  Susanne has held positions of increasing seniority across a range of business areas during her career at Novartis, having first joined the company as a sales representative in Germany in 1995. The majority of her roles have been in ...

IDEA Collider | Dan Skovronsky

Dan Skovronsky is the chief scientific officer of Eli Lilly and Company. He serves as senior vice president of science and technology and president of Lilly Research Laboratories. He also has responsibility for global business development. Dan joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since founding the company in 2004. At Lilly, Dan has held various roles, including vice president, tailored therapeutics; vice president, diabetes res...

IDEA Collider | Pharma Book Club | Brian Christian

With so much at stake in the application of AI/ Machine Learning to pharma, biotech and medicine, this wonderful book touches on biases, systems of learning, and the choices we have to make to properly harness the power of what is possible.  Email mike at ideapharma.com to enter a lottery to win a copy of the hardcover book, closing date 26th February. From the page at brianchristian.org: A jaw-dropping exploration of everything that goes wrong when we build AI systems and the movement to ...

IDEA Collider | Nick Wood, Benji Compston

  Syn is an award winning music agency and creative solutio, providing music strategy, composition, sound design and sonic branding for advertising, cinema and television, as well as music supervision, licensing and music curation services and our studios record voiceover, ADR and narration. In this interview, we discuss the user experience (patient, physician), via sound, for healthcare and pharma environments More information at https://syn.world

IDEA Collider | Riccardo Zacconi

Great interview with Riccardo on CNBC Find out more about PTEN Research at https://www.ptenresearch.org

IDEA Collider | John Tsai, MD

Covering a wide variety of topics, with a special focus on Novartis as one of the best examples of a learning organisation in pharma. On cultures of innovation, 'unbossing', decision making and measuring what matters John can be found on LinkedIn: https://www.linkedin.com/in/john-tsai-md-ab398b4/ or contacted by email at john_tsai.office at novartis.com

IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook

A discussion of The Playbook, from DiMe Society, Digital Clinical Measures  Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health  https://playbook.dimesociety.org  More on Andy (Andrea) Coravos here: http://www.andreacoravos.com  More on Jen (Jennifer) Goldsack here: https://en.wikipedia.org/wiki/Jennifer_Goldsack  More on DiMe Society here: https://www.dimesociety.org

IDEA Collider | Carinne Brouillon, Edward Hæggström, Rob Scott | Pharma Innovation Summit

Carinne Brouillon is a Member of the Board of Managing Directors, with responsibility for the Human Pharma Business Unit  Professional milestones  2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim  2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company  2012 – 2018 President of Janssen Therapeutics and Member of the Janssen North America Leadership Team  Edward Hæggström Born 1969. Finnish citizen. Co-founder o...

IDEA Collider | Defining and Measuring Innovation

This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Franchise Head, Neurology & Immunology, EMD Serono, Michael Schrage, Research Fellow, MIT Center for Digital Business; Visiting Fellow, Imperial Colleg...

IDEA Collider | Pharma Book Club | Lee Vinsel and Andrew L. Russell

ABOUT THE INNOVATION DELUSION  Innovation is the hottest buzzword in business. But what if our obsession with finding the next big thing has distracted us from the work that matters most? “The most important book I’ve read in a long time . . . It explains so much about what is wrong with our technology, our economy, and the world, and gives a simple recipe for how to fix it: Focus on understanding what it takes for your products and services to last.”—Tim O’Reilly, founder of O’Reilly Media...

IDEA Collider | Dr Peter Bach

Peter B. Bach is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients Dr. Bach described a 100-fold increase in cancer drug prices since 1965 after adjusting for inflation, and that the cost of an additional year of life from a cancer treatment in...

IDEA Collider | Jen Horonjeff

In conversation, discussing patient input into clinical programs, unmet need assessments, measurement and so much more. Jen was diagnosed with juvenile arthritis as an infant and now has a laundry list of other conditions and surprises (like a brain tumor). She is passionate about elevating and valuing the patient voice, and went on to become a health outcomes researcher, human factors engineer, FDA Consumer Representative, and, most importantly, a patient advocate. Jen earned a PhD in Envi...

IDEA Collider | Pharma Book Club | Gerald Posner

From the Amazon description: Pharmaceutical breakthroughs such as anti­biotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on pre­scription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. Pharma introduces brilliant scientists, in-...

IDEA Collider | Daphne Zohar

PureTech Health is an advanced, clinical-stage biopharmaceutical company developing novel medicines targeting serious diseases that result from dysfunctions in the nervous, immune, and gastrointestinal systems (brain-immune-gut or the “BIG” axis), which together represent the adaptive human systems. PureTech Health is at the forefront of understanding and addressing the biological processes and crosstalk associated with the BIG axis. By harnessing this emerging field of human biology, the Co...

IDEA Collider | Pharma Book Club | Jane Metcalfe

25 Visions for the Future of Our Species  We now have the tools to transform ourselves and our species. Greater health and longevity, enhanced brains, and engineered fertility are in the works. What’s just over the horizon is even more astonishing. We call this the neobiological frontier. The book is a collection of 25 essays, interviews, and works of fiction and art offering a big-picture perspective on the profound changes made possible by the merging of biology and technology. The book b...

IDEA Collider | Pharma Book Club | Thomas Hager

Chapter-by-chapter discussion, covering: opium/ heroin antibiotics contraceptive pill vaccines and more... Find more by Thomas Hager here: https://www.thomashager.net  

IDEA Collider | Pharma Book Club | Dr Jeremy Levin

Dr. Jeremy M. Levin is Chairman and CEO of Ovid Therapeutics Inc (NASDAQ:OVID), a company whose mission is to bring treatment to patients with rare neurological conditions. Dr. Levin is concurrently the chairman of the Biotechnology Innovation Organization (BIO). Prior to founding Ovid, Dr. Levin was president and CEO of Teva Pharmaceutical Industries Ltd., (TLV: TEVA) Before Teva, Dr. Levin was member of the executive committee Bristol-Myers Squibb Company (NYSE: BMY). In that capacity he w...

IDEA Collider | Pharma Book Club | Annie Duke

The books Annie recommends: Maria Konnikova The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win   Philip Tetlock, Dan Gardner Superforecasting: The Art and Science of Prediction   Don A Moore Perfectly Confident: How to Calibrate Your Decisions Wisely

IDEA Collider | Pharma Book Club | Peter Kolchinsky

Peter on Twitter: https://twitter.com/peterkolchinsky The book's website: https://peterkolchinsky.com/bio Link to the Katherine Eban discussion: 

IDEA Collider | Deborah Waterhouse

Deborah Waterhouse, CEO ViiV Healthcare Deborah was appointed to GSK’s Corporate Executive Team on 8th January 2020. She became Chief Executive Officer of ViiV Healthcare on 1st April 2017. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders. In this interview, we discuss cultures of innovation, innovation in the business model, purpose-driven innovation and more Deborah joined GSK in 1996 and was most recently the Senior Vice President of Primar...

IDEA Collider | Melinda Richter

For more on JLABS, go to https://jlabs.jnjinnovation.com/JLABSNavigator#/ As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to st...

IDEA Collider | Pharma Book Club | Clifton Leaf

In an archive recording, from 2015, the author of one of the best pharma-related books of the past decade, Clifton Leaf, gives us an insight into The Truth In Small Doses, Why We're Losing the War on Cancer-and How to Win It. (In this case, archive means that we thought we had lost the file, and then found it in a place we didn't expect!) Clifton, now Editor In Chief at Fortune Magazine, remains one of the most interesting voices in healthcare

IDEA Collider | Jack Scannell

Links to the papers we discuss Diagnosing the Decline of Pharmaceutical R&D efficiency (2012): https://www.nature.com/articles/nrd3681 When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis (2016): https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147215 Pharmaceutical Evolution: Clinical Selection versus Intelligent Design: https://www.innogen.ac.uk/sites/default/files/2019-08/Innogen-Working-Paper-115.pdf Jack can be contacted at j...

IDEA Collider | Pharma Book Club | Matt Ridley

Discussion of the new Matt Ridley book, How Innovation Works, published in May 2020. http://www.mattridley.co.uk Matt Ridley's books have sold over a million copies, been translated into 31 languages and won several awards. His books include The Red Queen, The Origins of Virtue, Genome, Nature via Nurture, Francis Crick, The Rational Optimist and The Evolution of Everything. His TED talk "When Ideas Have Sex" has been viewed more than two million times. He writes a weekly column in The Tim...

IDEA Collider | In conversation with Amrit Chaudhuri

Why Boston/ Cambridge and South San Francisco? Why not New York? Cultures of innovation The new way, scaling start-ups Critical factors for biotech hubs Europe/ The UK and the rest of the world Where does innovation come from? How is it defined?

IDEA Collider | Vinayak K Prasad | Pharma Book Club

Interview with Vinayak K. Prasad, author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer An essential listen for anyone involved in cancer R&D. Vinay is one of the more interesting voices on Twitter (@VPrasadMDMPH), and the book presents a wonderful exploration of what's right with oncology R&D and what's wrong. The interview reveals how positively he sees the opportunity to refocus on what matters to oncologists, and more importantly, to patients. The book is published...

IDEA Collider | Jackie Hunter

IDEA Pharma: IDEA Collider Jackie Hunter    https://www.youtube.com/watch?v=K59qefVIsbA     Interviewer: So welcome to another series of IDEA Collider with leaders in innovation. I'm delighted to be joined by Jackie Hunter of Benevolent AI. First of all, would you like to tell us more about you and about Benevolent?   Jackie Hunter: Yeah, I'm a board director of Benevolent AI. I've been with the company since 2016, where I came to set up the drop discovery and development arm of the b...

IDEA Collider | David Grainger

0:00 Defining innovation 01:00 Incremental innovation vs big changes 01:45 On designing back from the unmet need, and introducing innovation (Interruption by a phone call �) 02:54 Problem backwards vs solution forwards 03:55 On the ‘guided random walk’ and adoption of agility/ serendipity (low validity environments in pharma) 04:45 Prediction, hubris and certainty in process 06:50 The stopping rule in drug development (07:30 interruption by a phone call �) 07:50 Zombie projects 08:0...

IDEA Collider | Joseph Owens, Google X

IDEA Pharma: IDEA Collider Mike Rea talks with Joseph Owens from Google X   https://vimeo.com/269261531     Joseph Owens: Good to see you.    Mike Rea: Thanks for coming over. So, this is just for the benefit of everyone who has seen the previous live streams with me talking [in the camera]. This is hopefully the start of a new series of live streams and recordings where we're going to interview people that I find most interesting among the folks that I come across.   Joseph Owens: ...

IDEA Collider | In conversation with Nooman Haque

00:20 Introduction: what does Silicon Valley Bank's Life Sciences and Healthcare group do? 01:00 Nooman's background 01:30 How does SVB fit into the innovation ecosystem? 02:00 Lending to companies who don't have products 02:15 How does innovation happen: the myth of the lone inventor; the value of connections 03:15 Parallels to non-pharma innovation models and ecosystems 03:45: Innovation as the deployment into a market for the betterment of people and society 04:10: Invention, innov...

IDEA Collider | Katherine Eban, author of Bottle of Lies

Mike Rea in conversation with Katherine Eban. Katherine's website The book, on Amazon